Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02972060
Title ODM-201 vs Androgen Deprivation Therapy in Hormone naive Prostate Cancer
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

prostate cancer

Therapies

Triptorelin

Leuprolide

Degarelix

Goserelin

Darolutamide

Age Groups: adult | senior
Covered Countries ESP | BEL


No variant requirements are available.